Trials / Completed
CompletedNCT02697383
Ixazomib (MLN9708) and Dexamethasone in High Risk Smoldering Multiple Myeloma: A Clinical and Correlative Pilot Study
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to see what effects, good and/or bad, the combination of ixazomib and dexamethasone has on the patient and the smoldering multiple myeloma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ixazomib (MLN9708) | |
| DRUG | Dexamethasone |
Timeline
- Start date
- 2016-02-01
- Primary completion
- 2024-05-08
- Completion
- 2024-05-08
- First posted
- 2016-03-03
- Last updated
- 2024-05-13
Locations
6 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02697383. Inclusion in this directory is not an endorsement.